Screen and Detection for Early Stage Breast Cancers May Prevent Invasive Disease
Screening for and treatment of ductal carcinoma in situ (DCIS) is found to prevent subsequent invasive cancer.
Ductal Carcinoma In Situ (DCIS)
Aggressive Ductal Carcinoma More Likely in Older Individuals
Ductal Carcinoma (DCIS) is more likely to become invasive in people over 60 years old.
Study examines breast cancer mortality rate after diagnosis of ductal carcinoma in situ
Researchers estimate the 20-year breast cancer-specific death rate for women diagnosed with ductal carcinoma in situ to be 3.3%.
For patients with DCIS, risk of death higher for women under 35, black women
Women diagnosed with ductal carcinoma in situ have a 20-year breast cancer-specific death rate of 3.3%.
Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis
[OncoTargets and Therapy] This research examines the effect of radiotherapy on overall survival in women with locally excised ductal carcinoma in situ (DCIS).
Axillary lymph node evaluation performed frequently in DCIS
Although not usually recommended for women with localized cancer undergoing breast-conserving surgery, axillary lymph node evaluation is performed frequently in women with ductal carcinoma in situ (DCIS) breast cancer.
Multigene test can predict risk of recurrence for women with ductal carcinoma in situ
A multigene test was validated as a predictor of risk of disease recurrence among women treated with breast-conserving surgery alone for ductal carcinoma in situ (DCIS), according to data from a large study.
Gel formulation of tamoxifen significantly reduces side effects related to the oral formulation
A gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer reduced the growth of cancer cells to the same degree as the drug taken in oral form but with fewer side effects.
Treatment priorities set for early breast tumors
A team of stakeholders has detailed research priorities necessary to address gaps in knowledge about early breast tumors in women.
Local recurrence less likely after radiotherapy for DCIS
In women with ductal carcinoma in situ (DCIS), breast-conserving treatment combined with radiotherapy reduces the risk for local recurrence (LR), a recent study indicates.
- Loading...
Loading...
Loading... 
Loading...